Aurinia Pharmaceuticals Inc. will release its financial results for the three and twelve months ended December 31, 2025 and provide a business update on February 26, 2026. Aurinia’s management team will host a webcast and conference call the same day at 8:30 a.m. ET, accessible via here.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurinia Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260219418582) on February 19, 2026, and is solely responsible for the information contained therein.